NMR 850 Console Upgrade
Forecast New Requirement Updated
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Solicitation expected
- Estimated value
- $250,000 to $700,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- Not on record
- Points of contact
-
- CDER Acquisition Liaison cderacquisitions@fda.hhs.gov
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Food and Drug Administration is procuring an upgrade to an NMR 850 console and probe system to enhance analytical capability for drug characterization and assessment. The upgrade will address sensitivity limitations of the current 11-year-old equipment, enabling high-resolution 2D NMR analysis of oligonucleotides and biologic menotropin structures in support of complex generic ANDA and biologic BLA reviews. The estimated solicitation release is January 1, 2027, with award anticipated September 1, 2027.
The estimated award value ranges from $250,000 to $700,000. The point of contact is the FDA Acquisition Liaison at cderacquisitions@fda.hhs.gov.
Forecast text
NMR console and probe degrade over time (11 years), and currently we are limiited to study of high concentration drugs using 1D or low resolution 2D NMR. The 850 NMR needs upgrade for senstivity to characterize oligonucleotide and biologic menotropin structure, supporting complex generic ANDA and biologic BLA assessment.
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast